Oh AR, Jeong Y, Yu J, Minh Tam DT, et al. Hepatocyte Kctd17 inhibition ameliorates glucose intolerance and hepatic steatosis caused by obesity-induced Chrebp stabilization. Gastroenterology 2022 Nov 16:S0016-5085(22)01295.
PMID: 36402191